Skip to main content

Peer Review reports

From: Prognostic factors influencing overall survival in stage IV EGFR-mutant NSCLC patients treated with EGFR-TKIs

Original Submission
2 Nov 2024 Submitted Original manuscript
9 Nov 2024 Author responded Author comments - Yangkai Li
11 Nov 2024 Author responded Author comments - Yangkai Li
Resubmission - Version 2
9 Nov 2024 Submitted Manuscript version 2
12 Nov 2024 Author responded Author comments - Yangkai Li
Resubmission - Version 3
12 Nov 2024 Submitted Manuscript version 3
10 Dec 2024 Reviewed Reviewer Report
14 Dec 2024 Reviewed Reviewer Report
18 Dec 2024 Author responded Author comments - Yangkai Li
Resubmission - Version 4
18 Dec 2024 Submitted Manuscript version 4
27 Dec 2024 Reviewed Reviewer Report
29 Dec 2024 Reviewed Reviewer Report
9 Jan 2025 Author responded Author comments - Yangkai Li
Resubmission - Version 5
9 Jan 2025 Submitted Manuscript version 5
19 Jan 2025 Reviewed Reviewer Report
26 Jan 2025 Reviewed Reviewer Report
6 Feb 2025 Author responded Author comments - Yangkai Li
Resubmission - Version 6
6 Feb 2025 Submitted Manuscript version 6
22 Feb 2025 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
24 Feb 2025 Editorially accepted
13 Mar 2025 Article published 10.1186/s12890-025-03569-1

You can find further information about peer review here.

Back to article page